课题基金 / 基金详情

New cancer treatment focusing on genetic instability of the cancer stem cell

New cancer treatment focusing on genetic instability of the cancer stem cell
新的癌症治疗重点关注癌症干细胞的遗传不稳定性
批准号:
24659614
负责人:
MAEHARA Yoshihiko
金额:
$2.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012-04-01 至 2014-03-31

项目摘要

项目成果

MAEHARA Yoshihiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The cancer stem cell remains to be resistant to the treatment such as chemotherapy or the radiation. We can propose a new treatment to reduce recurrence and metastasis by targetting the cancer stem cell. Because a cancer is exposed to hypoxia and chemical irritation partially, some cells become a stem like cell and become to generate genetic instability.In our experiment,oxidative stress (OS) causes DNA damage and chromosome instability that may lead to carcinogenesis. OS is also suggested to contribute to an increase in aneuploid cells. However, it is not clear how OS is involved in the regulation of SAC and contributes to carcinogenesis associated with aneuploidy. Here we show that an oxidant (KBrO3) activated the p53 signaling pathway and suppressed the expression of SAC factors, BubR1, and Mad2, in human diploid fibroblast MRC5 cells. This suppression was dependent on functional p53 and reactive oxygen species.
期刊论文(58)
专著(0)
科研奖励(0)
会议论文
Impact of second-line and later cetuximab-containing therapy and KRAS genotypes in patients with metastatic colorectal cancer: a multicenter study in Japan.
二线及后续含西妥昔单抗治疗和 KRAS 基因型对转移性结直肠癌患者的影响:日本的一项多中心研究。
DOI: 10.1007/s00595-013-0716-0
发表时间: 2014
期刊: Surg Today.
影响因子: --
作者: [Saeki H, Emi Y, Kumashiro R, Otsu H, Kawano H, Ando K, Ida S, Kimura Y, Tokunaga E, Oki E, Morita M, Shimokawa M, Maehara Y]
通讯作者: Maehara Y
Hepatic vein waveform and splenomegaly predict improvement of prothrombin time after splenectomy in hepatitis C virus-related cirrhotic patients.
肝静脉波形和脾肿大可预测丙型肝炎病毒相关肝硬化患者脾切除术后凝血酶原时间的改善。
DOI: 10.1111/hepr.12040
发表时间: 2012
期刊: Hepatol Res.
影响因子: --
作者: [Kinjo N, Nagao Y, Akahoshi T, Masahiro K, Hashimoto N, Uehara H, Kawanaka H, Tomikawa M, Shirabe K, Hashizume M, Maehara Y.]
通讯作者: Maehara Y.
DOI: 10.1002/cam4.101
发表时间: 2013-08
期刊: CANCER MEDICINE
影响因子: 4
作者: [Ikawa-Yoshida, Ayae, Ando, Koji, Oki, Eiji, Saeki, Hiroshi, Kumashiro, Ryuichi, Taketani, Kenji, Ida, Satoshi, Tokunaga, Eriko, Kitao, Hiroyuki, Morita, Masaru, Maehara, Yoshihiko]
通讯作者: Maehara, Yoshihiko
DOI: 10.1111/hepr.12070
发表时间: 2013-11
期刊: Hepatology Research
影响因子: 4.2
作者: [H. Konishi;K. Shirabe;S. Yoshiya;T. Ikeda;T. Ikegami;T. Yoshizumi;Ayae Ikawa-Yoshida;T. Motomura;T. Fukuhara;Y. Maehara]
通讯作者: H. Konishi;K. Shirabe;S. Yoshiya;T. Ikeda;T. Ikegami;T. Yoshizumi;Ayae Ikawa-Yoshida;T. Motomura;T. Fukuhara;Y. Maehara
40
    Development of the the innovative treatment and the proposal of the Self-niche hypothesis in refractory cancer
    • 批准号:
      16K15620
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2016
    • 负责人:
      MAEHARA Yoshihiko
    • 依托单位:
    Pre-clinical application of an innovative therapy, "BioKnife", to malignant pleural mesothelioma
    • 批准号:
      24249071
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $23.63万
    • 财政年份:
      2012
    • 负责人:
      MAEHARA Yoshihiko
    • 依托单位:
    Development of'BioKnife', a uPA-targeted oncolytic Sendai virus to treat intractable malignancies.
    • 批准号:
      22659246
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.07万
    • 财政年份:
      2010
    • 负责人:
      MAEHARA Yoshihiko
    • 依托单位:
    A novel treatment strategy for digestive system cancer against angiogenic signal in tumor stroma using nanosize particle.
    • 批准号:
      21249072
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.03万
    • 财政年份:
      2009
    • 负责人:
      MAEHARA Yoshihiko
    • 依托单位:
    海外基金